ClinicalTrials.govpublic full text
Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)
multiple sclerosis, tecfidera, dmf, dimethyl fumarate, fingolimod, glatiramer acetate, teriflunomide, gilenya, copaxone, aubagio, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 918615
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.